Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses

Fig. 2

Immune infiltrate can be detected in mice challenged with B16-luc a Percentage CD11c+ of live non-lymphocytes (dendritic cells), b percentage F480+ of non-lymphocytes (macrophages), c percentage CD3+ of lymphocytes (T cells), d percentage CD4+ of T cells, e percentage CD8+ of T cells and f percentage CD19+ of lymphocytes (B cells) in tumours or draining lymph nodes. Data are shown as mean ± standard deviation, n = 4–5, representative of two individual experiments. One-way ANOVA with Turkey post-hoc test was performed. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page